Biden Administration Unveils First Drugs for Medicare Price Negotiationsnews2023-08-29T22:50:39+00:00August 29th, 2023|The New York Times|
Biden Administration Selects Drugs for Medicare Price Negotiationsnews2023-08-29T22:03:46+00:00August 29th, 2023|The New York Times|
New RSV Vaccines Aren’t Covered by Some Health Insurance Plansnews2023-08-25T19:55:21+00:00August 25th, 2023|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
Leqembi: lo que hay que saber sobre el fármaco contra el alzhéimernews2023-07-08T11:00:12+00:00July 8th, 2023|The New York Times|
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDAnews2023-07-06T22:20:07+00:00July 6th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
Retiree Medical Costs Expected to Stay Flat in 2023news2023-06-30T13:00:17+00:00June 30th, 2023|The New York Times|
Merck Sues Over Medicare Drug-Price Negotiation Lawnews2023-06-06T18:41:33+00:00June 6th, 2023|The New York Times|
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Findsnews2023-05-10T21:49:51+00:00May 10th, 2023|The New York Times|
